437384-18-4

Upstream product

• 437384-17-3 7-chloro-2-(4-methoxyphenyl)pyrazolo[1,5-a]pyridine 
• 108-24-7 acetic anhydride 
• 109-63-7 boron trifluoride diethyl etherate 
• 144-55-8 sodium hydrogencarbonate 
• 94-30-4 ethyl 4-methoxybenzoate 
• 437384-16-2 2-(6-chloro-2-pyridinyl)-1-(4-methoxyphenyl)ethanone oxime 
• 437384-15-1 2-(6-chloro-2-pyridinyl)-1-(4-methoxyphenyl)ethanone 
• 18368-63-3 6-chloro-2-picoline 

Downstream Products

• 437384-19-5 1-[7-(cyclopentylamino)-2-(4-methoxyphenyl)pyrazolo[1,5-a]pyridin-3-yl]ethanone 
• 460078-20-0 cyclopentyl-[3-(2-cyclopentylamino-pyrimidin-4-yl)-2-(4-methoxy-phenyl)-pyrazolo[1,5-a]pyridin-7-yl]-amine 
• 460078-26-6 4-[7-cyclopentylamino-3-(2-cyclopentylamino-pyrimidin-4-yl)-pyrazolo[1,5-a]pyridin-2-yl]-phenol 
• 437384-20-8 (2E)-1-[7-(cyclopentylamino)-2-(4-methoxyphenyl)pyrazolo[1,5-a]pyridin-3-yl]-3-(dimethylamino)-2-propen-1-one 

Relevant academic research and scientific papers

Synthesis of novel substituted 2-phenylpyrazolopyridines with potent activity against herpesviruses

Herpesviruses are a significant source of human disease; amongst these herpes simplex virus 1 (HSV-1) and HSV-2 are very prevalent and cause recurrent infections. We recently identified a pyrazolo[1,5-a]pyridine scaffold that showed promising activity aga

Therapeutic compounds

The present invention provides compounds of formula (I): wherein all variables are as defined herein, pharmaceutical compositions containing the same, processes for preparing the same and their use as pharmaceutical agents. 1